Cohort study for Bardet-Biedl and Alström syndromes
Part of Brain & nervous system, Eyes & vision, Genetic & congenital clinical trials.
This study follows people with Bardet-Biedl syndrome (BBS) or Alström syndrome (ALMS) to spot early vision, metabolic (body chemistry/energy), and kidney problems. You may be asked to have clinical checks over time to help researchers better understand how these complications develop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Bardet-Biedl (BBS) or Alström (ALMS), or have a known gene mutation linked to these conditions
- You can join with proper consent: you (or a parent/guardian/legal representative) signs before any study procedures
- You are not required to be in a different “interventional” clinical trial that would block participation right now
- You do not have a serious active health problem that could interfere with the study’s measurements
- You are able to understand the study information (or can have a legally allowed support/translation arrangement), and you are not under special legal protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health and genetic information from people with Bardet-Biedl syndrome. It may help researchers better understand the condition and improve future care by building a clear group of eligible patients.
This trial tests a drug called setmelanotide for people with Bardet-Biedl Syndrome (a rare genetic condition) or other severe genetic obesity. It looks at how well the drug works in real-world settings, not just in a lab.
This early-phase trial tests a gene therapy called AXV-101 for children with vision loss caused by BBS1 genetic mutations. The goal is to see if it can help slow or stop retinal damage.
This report describes a rare case of Bardet-Biedl syndrome in a teenager from Syria. The trial is open to anyone, so it may help doctors learn more about this condition.
This study follows people diagnosed with Alport syndrome to better understand the condition and its effects. It may help researchers learn what to watch for over time and how the disease progresses.
This study looks at immune cells in blood to better understand rare brain conditions caused by genetic changes. It may help researchers understand why symptoms happen and how the immune system is involved.
Hear when a new Bardet Biedl Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.